The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of pain and stroke are listed in the xact instructions for use as known potential patients effect potentially associated with carotid stents and embolic protection systems.Based on the case information, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.Exemption number (b)(4).
|
It was reported that the procedure was to treat a carotid artery.A xact carotid stent system was used for this procedure and deployed without issue following the instructions for use (ifu).An unspecified balloon was used for standard post-dilatation of the lesion.However the patient started to feel discomfort.At this point, the filter was retrieved and neurological, visual, and verbal tests were done.It was noted that the patient's left eye drooped and vision changes occurred, when the patient smiled the face started to droop, speech was slurred; the patient had a stroke.Tissue plasminogen activator medication was provided to the patient immediately.There is no determination on what caused the stroke.Patient is doing well and recovered.No additional information was provided.
|